Media Summary: Jennifer Maguire, PhD, Acting Director for the Office of Throughout the COVID-19 public health emergency, Christopher Middendorf, US FDA India Office, shares how the FDA's India Office supports the overall FDA mission related to ...
Update On Cder S Quality - Detailed Analysis & Overview
Jennifer Maguire, PhD, Acting Director for the Office of Throughout the COVID-19 public health emergency, Christopher Middendorf, US FDA India Office, shares how the FDA's India Office supports the overall FDA mission related to ... To discuss the plausible mechanism guidance and its applicability to both CBER and Real-world evidence is information on patient's health and health care that comes from multiple sources within and outside the ... This presentation provided information about the Small Business and Industry Assistance (SBIA) and its mission. Topics ...
This lecture is part of the NIH Clinical and Translational Research Summer Course which provides an online opportunity for ... Data standards make the exchange of data predictable, consistent, and in a form that a scientific tool can use. Data standards help ... Janice T. Brown, MS, Branch Chief for the Division of Internal Policies and Programs, in the Office of Pharmaceutical Stefanie Kraus, JD, MPH, Senior Regulatory Council for the Division of Regulatory Policy (ORP) II, discusses how regulatory ... Learn directly from the FDA's regulatory experts in medical product centers: drugs, devices, and biologics. This course is designed ... The FDA adapted to the challenges presented by the COVID-19 public health emergency by using all tools at our disposal to take ...
Howard Holstein discusses the difference between the two centers within the FDA. Presenters Geoffrey Wu and Bhagwant Rege respond to audience questions. Learn more at: ... This inaugural webinar was a collaborative effort between FDA and NIH's Small Business Innovation Research (SBIR) ...
